Healthcare companies might not be completely immune to an economic downturn, but they are generally more resilient than companies in several other sectors. Despite higher input costs and a worsening macro backdrop, some healthcare companies recently reported better-than-anticipated results for the second quarter. We used the TipRanks Stock Comparison Tool to pit Johnson & Johnson, Abbott, and UnitedHealth against each other to pick the healthcare stock that Wall Street analysts are more bullish about. Johnson & Johnson (NYSE: JNJ) JNJ topped analysts’ second-quarter expectations, with sales rising 3% to $24 billion and adjusted earnings per share (EPS) up 4.4% to $2.59.
https://www.tipranks.com/news/article/which-healthcare-stock-is-wall-street-more-confident-on-post-q2-results?utm_source=advfn.com&utm_medium=referral
UnitedHealth (NYSE:UNH)
Gráfica de Acción Histórica
De Sep 2022 a Oct 2022 Haga Click aquí para más Gráficas UnitedHealth.
UnitedHealth (NYSE:UNH)
Gráfica de Acción Histórica
De Oct 2021 a Oct 2022 Haga Click aquí para más Gráficas UnitedHealth.